These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2611450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Case studies of drug testing in the workplace.
    Blume S, Cannella JM, Muir E, Stein P, Weihenmeyer E.
    Bull N Y Acad Med; 1989 Feb; 65(2):215-42. PubMed ID: 2611457
    [No Abstract] [Full Text] [Related]

  • 3. Drug testing in the private and public sectors.
    Walsh JM.
    Bull N Y Acad Med; 1989 Feb; 65(2):166-72. PubMed ID: 2611451
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of the occupational physician in substance abuse.
    Lambert SD.
    Occup Med; 2002 Feb; 17(1):1-12, iii. PubMed ID: 11726332
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Health promotion in the workplace: alcohol and drug abuse. Report of a WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1993 Feb; 833():1-34. PubMed ID: 8367980
    [No Abstract] [Full Text] [Related]

  • 9. Drug screening in the workplace: use, abuse and implications.
    Grabowski J, Silverman PB.
    NIDA Res Monogr; 1989 Feb; 95():225-31. PubMed ID: 2640968
    [No Abstract] [Full Text] [Related]

  • 10. Just say 'No'. Policies, procedures, and legal considerations for maintaining a drug-free work-place environment.
    Slogoff RJ.
    Provider; 1998 Jan; 24(1):49-50. PubMed ID: 10175136
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM.
    Forensic Sci Int; 2008 Jan 30; 174(2-3):111-9. PubMed ID: 17434274
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR, Zaloshnja E, Spicer RS.
    Accid Anal Prev; 2007 May 30; 39(3):565-73. PubMed ID: 17125723
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Survey of employer anti-drug programs.
    Hayghe H.
    NIDA Res Monogr; 1990 May 30; 100():177-207. PubMed ID: 2132771
    [No Abstract] [Full Text] [Related]

  • 17. Alcohol and drug abuse in the workplace in broad perspective.
    Weiss C, Millman RB.
    Bull N Y Acad Med; 1989 Feb 30; 65(2):173-84. PubMed ID: 2611452
    [No Abstract] [Full Text] [Related]

  • 18. The synergism of health promotion and restoration in the prevention of substance abuse in the workplace.
    Miller RE, Shain M, Crim D, Golaszewski TJ.
    Health Values; 1985 Feb 30; 9(5):50-8. PubMed ID: 10317664
    [Abstract] [Full Text] [Related]

  • 19. Testing for drugs of abuse in urine.
    Turk J.
    Mo Med; 1989 Jun 30; 86(6):337-40. PubMed ID: 2755453
    [Abstract] [Full Text] [Related]

  • 20. Drug testing in the workplace: integrating medical review officer duties into occupational medicine.
    Smith DE, Glatt W, Tucker DE, Deutsch R, Seymour RB.
    Occup Med; 2002 Jun 30; 17(1):79-90, v. PubMed ID: 11726338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.